CBX3 and nonpapillary renal cell carcinoma: CBX3 could potentially serve as a predictive biomarker for ccRCC [9–12], and its significant association with the infiltration level of immune cells are apparent; however, the precise molecular mechanisms by which CBX3 accelerates the development of ccRCC remain elusive.